Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Systemic Inflammatory Response Syndrome | 12 | 2025 | 198 | 1.520 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 5 | 2023 | 74 | 1.240 |
Why?
|
| Coronary Vessel Anomalies | 10 | 2021 | 289 | 1.070 |
Why?
|
| Coronary Vessels | 6 | 2023 | 566 | 0.920 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 772 | 0.870 |
Why?
|
| Myocarditis | 2 | 2022 | 137 | 0.840 |
Why?
|
| Pericarditis | 1 | 2022 | 43 | 0.730 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2021 | 16 | 0.730 |
Why?
|
| Gastrostomy | 1 | 2021 | 92 | 0.690 |
Why?
|
| Hyperglycemia | 1 | 2022 | 242 | 0.670 |
Why?
|
| Pneumonia, Viral | 2 | 2022 | 396 | 0.660 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2022 | 149 | 0.660 |
Why?
|
| Heart Defects, Congenital | 6 | 2025 | 1885 | 0.640 |
Why?
|
| Pulmonary Atresia | 1 | 2019 | 48 | 0.620 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 29 | 0.620 |
Why?
|
| Hospitalists | 1 | 2019 | 46 | 0.600 |
Why?
|
| Tracheostomy | 1 | 2021 | 202 | 0.600 |
Why?
|
| Pneumonia | 1 | 2022 | 343 | 0.590 |
Why?
|
| Coronary Circulation | 1 | 2019 | 221 | 0.580 |
Why?
|
| Child | 39 | 2025 | 25917 | 0.580 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2025 | 1163 | 0.570 |
Why?
|
| Vaccination | 3 | 2023 | 1019 | 0.570 |
Why?
|
| Ventricular Function, Left | 6 | 2025 | 556 | 0.540 |
Why?
|
| Pericardium | 1 | 2017 | 87 | 0.520 |
Why?
|
| Immunoglobulins, Intravenous | 4 | 2023 | 151 | 0.510 |
Why?
|
| Heart Neoplasms | 1 | 2017 | 106 | 0.500 |
Why?
|
| Teratoma | 1 | 2017 | 131 | 0.500 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2020 | 267 | 0.470 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 795 | 0.450 |
Why?
|
| Gestational Age | 2 | 2017 | 1230 | 0.440 |
Why?
|
| Hospitalization | 2 | 2025 | 1919 | 0.420 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2025 | 382 | 0.410 |
Why?
|
| Fetal Diseases | 1 | 2017 | 462 | 0.410 |
Why?
|
| Connective Tissue Diseases | 2 | 2023 | 32 | 0.400 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2023 | 57 | 0.380 |
Why?
|
| Child, Preschool | 20 | 2025 | 14897 | 0.370 |
Why?
|
| Coronary Angiography | 6 | 2021 | 485 | 0.370 |
Why?
|
| Fetal Heart | 3 | 2017 | 136 | 0.370 |
Why?
|
| Magnetic Resonance Imaging, Cine | 5 | 2025 | 170 | 0.360 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2025 | 1008 | 0.350 |
Why?
|
| Coronary Aneurysm | 2 | 2023 | 33 | 0.350 |
Why?
|
| Humans | 52 | 2025 | 134225 | 0.350 |
Why?
|
| Infliximab | 2 | 2021 | 68 | 0.330 |
Why?
|
| Male | 35 | 2025 | 66215 | 0.320 |
Why?
|
| Aorta, Thoracic | 3 | 2021 | 544 | 0.320 |
Why?
|
| Hypoplastic Left Heart Syndrome | 3 | 2018 | 272 | 0.310 |
Why?
|
| Adolescent | 22 | 2025 | 20647 | 0.300 |
Why?
|
| Female | 33 | 2025 | 72054 | 0.290 |
Why?
|
| Echocardiography | 6 | 2025 | 1132 | 0.290 |
Why?
|
| Myocardial Perfusion Imaging | 4 | 2021 | 58 | 0.280 |
Why?
|
| Infant | 13 | 2025 | 13263 | 0.270 |
Why?
|
| Prenatal Diagnosis | 2 | 2025 | 633 | 0.270 |
Why?
|
| Retrospective Studies | 13 | 2025 | 17591 | 0.270 |
Why?
|
| Myocardial Contraction | 2 | 2019 | 270 | 0.260 |
Why?
|
| Echocardiography, Doppler | 2 | 2019 | 174 | 0.260 |
Why?
|
| Glucocorticoids | 3 | 2023 | 401 | 0.240 |
Why?
|
| Stroke Volume | 3 | 2023 | 535 | 0.230 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 4008 | 0.230 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2025 | 28 | 0.230 |
Why?
|
| Immune System Diseases | 1 | 2025 | 52 | 0.220 |
Why?
|
| Exercise | 2 | 2021 | 875 | 0.220 |
Why?
|
| United States | 11 | 2025 | 11798 | 0.210 |
Why?
|
| Fractional Flow Reserve, Myocardial | 2 | 2021 | 55 | 0.200 |
Why?
|
| Cardiac Catheterization | 5 | 2020 | 669 | 0.200 |
Why?
|
| Coronary Artery Disease | 2 | 2021 | 896 | 0.200 |
Why?
|
| Patient Care Team | 2 | 2025 | 577 | 0.200 |
Why?
|
| Health Status Disparities | 1 | 2025 | 252 | 0.190 |
Why?
|
| Vascular Surgical Procedures | 2 | 2017 | 563 | 0.190 |
Why?
|
| Time Factors | 6 | 2025 | 6595 | 0.180 |
Why?
|
| Infant, Newborn | 5 | 2025 | 8640 | 0.180 |
Why?
|
| Aftercare | 1 | 2022 | 157 | 0.180 |
Why?
|
| Disease Management | 3 | 2025 | 567 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 298 | 0.180 |
Why?
|
| Shock | 1 | 2022 | 99 | 0.170 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 54 | 0.170 |
Why?
|
| Syncope | 1 | 2021 | 54 | 0.170 |
Why?
|
| Vascular Resistance | 2 | 2018 | 203 | 0.170 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 187 | 0.170 |
Why?
|
| Fever | 2 | 2021 | 312 | 0.170 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2020 | 21 | 0.160 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 3759 | 0.160 |
Why?
|
| Weight Gain | 1 | 2022 | 413 | 0.160 |
Why?
|
| Databases, Factual | 2 | 2021 | 1260 | 0.150 |
Why?
|
| Risk Factors | 9 | 2022 | 11196 | 0.150 |
Why?
|
| Longevity | 1 | 2020 | 159 | 0.150 |
Why?
|
| Liver Transplantation | 2 | 2019 | 1122 | 0.150 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 5466 | 0.150 |
Why?
|
| Patient Discharge | 1 | 2022 | 520 | 0.150 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2019 | 111 | 0.150 |
Why?
|
| Sinus of Valsalva | 1 | 2018 | 35 | 0.140 |
Why?
|
| Predictive Value of Tests | 6 | 2021 | 2319 | 0.140 |
Why?
|
| Pandemics | 2 | 2022 | 1193 | 0.140 |
Why?
|
| Prospective Studies | 8 | 2024 | 6617 | 0.140 |
Why?
|
| MEDLINE | 1 | 2017 | 20 | 0.140 |
Why?
|
| Mitral Valve | 2 | 2016 | 272 | 0.130 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 319 | 0.130 |
Why?
|
| Myocardial Bridging | 1 | 2017 | 14 | 0.130 |
Why?
|
| Aorta | 2 | 2017 | 562 | 0.130 |
Why?
|
| Hydrops Fetalis | 1 | 2017 | 85 | 0.130 |
Why?
|
| Diseases in Twins | 1 | 2017 | 99 | 0.130 |
Why?
|
| Age Factors | 6 | 2020 | 2997 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2020 | 364 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2022 | 385 | 0.130 |
Why?
|
| Computed Tomography Angiography | 4 | 2020 | 214 | 0.130 |
Why?
|
| Chest Pain | 1 | 2017 | 133 | 0.130 |
Why?
|
| Survival Rate | 2 | 2019 | 2214 | 0.130 |
Why?
|
| Incidence | 2 | 2022 | 3424 | 0.130 |
Why?
|
| Aortic Coarctation | 1 | 2017 | 108 | 0.130 |
Why?
|
| Risk Assessment | 4 | 2020 | 3754 | 0.120 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2016 | 113 | 0.120 |
Why?
|
| Steroid Metabolism, Inborn Errors | 1 | 2015 | 3 | 0.120 |
Why?
|
| Cholic Acids | 1 | 2015 | 16 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2017 | 182 | 0.120 |
Why?
|
| Athletes | 1 | 2016 | 74 | 0.120 |
Why?
|
| Drainage | 1 | 2017 | 265 | 0.120 |
Why?
|
| Pregnancy | 5 | 2025 | 7600 | 0.120 |
Why?
|
| Hypertension | 1 | 2024 | 1409 | 0.120 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 41 | 0.120 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2015 | 22 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 474 | 0.120 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 207 | 0.120 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2015 | 44 | 0.110 |
Why?
|
| Hemodynamics | 4 | 2022 | 871 | 0.110 |
Why?
|
| Oxygen | 1 | 2018 | 580 | 0.110 |
Why?
|
| Hyperoxia | 1 | 2016 | 130 | 0.110 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 637 | 0.110 |
Why?
|
| Family | 1 | 2017 | 597 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2015 | 160 | 0.100 |
Why?
|
| Texas | 2 | 2019 | 3719 | 0.100 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 217 | 0.100 |
Why?
|
| Quality of Life | 2 | 2021 | 2163 | 0.100 |
Why?
|
| Registries | 1 | 2020 | 1588 | 0.100 |
Why?
|
| Norwood Procedures | 1 | 2014 | 105 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 553 | 0.090 |
Why?
|
| Adult | 5 | 2024 | 31962 | 0.080 |
Why?
|
| Heart Transplantation | 1 | 2017 | 889 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2024 | 5225 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2014 | 804 | 0.080 |
Why?
|
| Cardiology | 1 | 2014 | 521 | 0.080 |
Why?
|
| Exercise Test | 2 | 2020 | 263 | 0.080 |
Why?
|
| Receptors, LDL | 2 | 2019 | 103 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2025 | 1982 | 0.070 |
Why?
|
| Biomechanical Phenomena | 2 | 2019 | 261 | 0.070 |
Why?
|
| Length of Stay | 2 | 2025 | 1392 | 0.060 |
Why?
|
| Scrub Typhus | 1 | 2025 | 11 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3172 | 0.060 |
Why?
|
| North America | 1 | 2025 | 264 | 0.060 |
Why?
|
| Triage | 1 | 2025 | 148 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 116 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 475 | 0.050 |
Why?
|
| Young Adult | 3 | 2024 | 9963 | 0.050 |
Why?
|
| Thoracic Surgery | 1 | 2025 | 166 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2018 | 1493 | 0.050 |
Why?
|
| Rivaroxaban | 1 | 2023 | 58 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2024 | 202 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 920 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2024 | 411 | 0.050 |
Why?
|
| Infant Mortality | 1 | 2022 | 180 | 0.040 |
Why?
|
| Potassium | 1 | 2022 | 288 | 0.040 |
Why?
|
| Syncope, Vasovagal | 1 | 2021 | 5 | 0.040 |
Why?
|
| Prednisolone | 1 | 2021 | 74 | 0.040 |
Why?
|
| Unconsciousness | 1 | 2021 | 18 | 0.040 |
Why?
|
| Platelet Count | 1 | 2021 | 144 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 2021 | 100 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 308 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 780 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2020 | 13105 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 471 | 0.040 |
Why?
|
| Algorithms | 2 | 2020 | 1739 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 483 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2021 | 82 | 0.040 |
Why?
|
| Perfusion | 1 | 2021 | 214 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 757 | 0.040 |
Why?
|
| Aspirin | 1 | 2021 | 231 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2019 | 78 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 728 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 317 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 76 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2024 | 1423 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2019 | 264 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2018 | 128 | 0.040 |
Why?
|
| Umbilical Arteries | 1 | 2018 | 98 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2023 | 626 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 252 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 296 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 87 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 332 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1470 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 298 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 258 | 0.030 |
Why?
|
| Replantation | 1 | 2017 | 57 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 478 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 827 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 3119 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1388 | 0.030 |
Why?
|
| Critical Care | 1 | 2022 | 698 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2021 | 1006 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 199 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 536 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2265 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 519 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1732 | 0.030 |
Why?
|
| Seizures | 1 | 2021 | 892 | 0.030 |
Why?
|
| Heart Septum | 1 | 2015 | 56 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 601 | 0.030 |
Why?
|
| Diastole | 1 | 2015 | 184 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2015 | 124 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 1222 | 0.030 |
Why?
|
| Heart Atria | 1 | 2016 | 339 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2014 | 79 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2016 | 468 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 2016 | 360 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 317 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 468 | 0.020 |
Why?
|
| Aged | 2 | 2022 | 21822 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 5085 | 0.020 |
Why?
|
| DNA | 1 | 2015 | 1685 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 3056 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2685 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 3226 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 6350 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 29430 | 0.010 |
Why?
|